ATE185815T1 - Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen - Google Patents

Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen

Info

Publication number
ATE185815T1
ATE185815T1 AT93905796T AT93905796T ATE185815T1 AT E185815 T1 ATE185815 T1 AT E185815T1 AT 93905796 T AT93905796 T AT 93905796T AT 93905796 T AT93905796 T AT 93905796T AT E185815 T1 ATE185815 T1 AT E185815T1
Authority
AT
Austria
Prior art keywords
antigen
thermal
injury
icam
necrosis
Prior art date
Application number
AT93905796T
Other languages
English (en)
Inventor
Peter E Lipsky
William J Mileski
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE185815T1 publication Critical patent/ATE185815T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93905796T 1992-02-28 1993-02-05 Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen ATE185815T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84311292A 1992-02-28 1992-02-28

Publications (1)

Publication Number Publication Date
ATE185815T1 true ATE185815T1 (de) 1999-11-15

Family

ID=25289108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905796T ATE185815T1 (de) 1992-02-28 1993-02-05 Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen

Country Status (7)

Country Link
US (1) US6203793B1 (de)
EP (1) EP0628057B1 (de)
AT (1) ATE185815T1 (de)
AU (1) AU3657893A (de)
CA (1) CA2131190C (de)
DE (1) DE69326829D1 (de)
WO (1) WO1993017047A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695760A (en) * 1995-04-24 1997-12-09 Boehringer Inglehiem Pharmaceuticals, Inc. Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
AU6721696A (en) * 1996-07-15 1998-03-06 Human Genome Sciences, Inc. Cd44-like protein
US6849712B1 (en) 1998-01-22 2005-02-01 Regents Of The University Of Minnesota Peptides with β1 integrin subunit dependent cell adhesion modulating activity
JP2005500278A (ja) * 2001-06-06 2005-01-06 ブイ ペリコン，ニコラス アルカノールアミンを使用する局所治療
US6319942B1 (en) * 2001-06-06 2001-11-20 Nicholas V. Perricone Topical scar treatments using alkanolamines
CA2544678C (en) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
MX2010004281A (es) * 2007-10-19 2010-09-10 Sarcode Corp Composiciones y metodos para el tratamiento de la retinopatia diabetica.
JP2011521896A (ja) * 2008-04-15 2011-07-28 サーコード コーポレイション 免疫関連障害に対する局部治療に使用するための局所ｌｆａ−１アンタゴニスト
US8437832B2 (en) * 2008-06-06 2013-05-07 Biosense Webster, Inc. Catheter with bendable tip

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA39161C2 (uk) 1984-07-06 2001-06-15 Новартіс Аг Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
US4965271A (en) 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
EP0314863B1 (de) * 1987-11-02 1994-12-07 Baylor College Of Medicine Verwendung von ICAM-1 oder ihre funktionelle Derivate zur Behandlung unspezifischer Entzündungen
US5009889A (en) 1987-12-31 1991-04-23 Oklahoma Medical Research Foundation Treatment of dysfunctional vascular endothelium using activated protein C
CA2011633C (en) * 1989-03-09 2007-05-15 Timothy A. Springer Intercellular adhesion molecule - 2 and its binding ligands
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
WO1991019511A1 (en) * 1990-06-18 1991-12-26 The General Hospital Corporation CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS

Also Published As

Publication number Publication date
US6203793B1 (en) 2001-03-20
WO1993017047A1 (en) 1993-09-02
EP0628057A1 (de) 1994-12-14
CA2131190C (en) 2008-08-12
EP0628057B1 (de) 1999-10-20
CA2131190A1 (en) 1993-09-02
AU3657893A (en) 1993-09-13
EP0628057A4 (de) 1996-07-10
DE69326829D1 (de) 1999-11-25

Similar Documents

Publication Publication Date Title
Coutinho et al. Effect of passive stretching on the immobilized soleus muscle fiber morphology
Rochkind et al. Systemic effects of low‐power laser irradiation on the peripheral and central nervous system, cutaneous wounds, and burns
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
Stehlin Jr et al. Soft tissue sarcomas of the extremity: multidisciplinary therapy employing hyperthermic perfusion
DE69525151T2 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
DE69805202D1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
DE69731652D1 (de) Verfahren zur behandlung von endothelialen verletzungen
DE69326829D1 (de) Verwendung einer therapeutischen ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON VERBRENNUNGEN
Brown et al. An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts
Rochkind et al. New methods of treatment of severely injured sciatic nerve and spinal cord: An experimental study
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69310528T2 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
ATE131064T1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
Derbyshire Observations on the treatment of ganglia with a report on hydrocortisone
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
CAMPOS Treatment of bone cysts by intracavity injection of methylprednisolone acetate: a message to orthopedic surgeons.
Hinshaw et al. Effects of cortisone on the healing of disrupted abdominal wounds
Enwemeka Therapeutic light
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
NO982935L (no) Hyaluronsyre reseptor bindemiddel og anvendelse derav
Bayat et al. Low-level laser therapy improves early healing of medial collateral ligament injuries in rats
Rochkind et al. Low-energy laser irradiation and the nervous system: Method and results
Cheng et al. Coverage of wounds in the distal lower leg by advancement of an enlarged medial gastrocnemius skin flap

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties